M. Foucault, L. Thomas, S. Goussard, B. Branchini, and C. Grillot-courvalin, In Vivo Bioluminescence Imaging for the Study of Intestinal Colonization by Escherichia coli in Mice, Applied and Environmental Microbiology, vol.76, issue.1, pp.264-74, 2010.
DOI : 10.1128/AEM.01686-09

P. Gómez and A. Buckling, Bacteria-Phage Antagonistic Coevolution in Soil, Science, vol.21, issue.3, pp.106-115, 2011.
DOI : 10.1111/j.1420-9101.2008.01501.x

H. Kunisaki and Y. Tanji, Intercrossing of phage genomes in a phage cocktail and stable coexistence with Escherichia coli O157:H7 in anaerobic continuous culture, Applied Microbiology and Biotechnology, vol.19, issue.5, pp.1533-1573, 2010.
DOI : 10.1007/s00253-009-2230-2

S. Butler and A. Camilli, Going against the grain: chemotaxis and infection in Vibrio cholerae, Nature Reviews Microbiology, vol.156, issue.8, pp.611-631, 2005.
DOI : 10.1128/AEM.69.7.4200-4204.2003

M. Zahid, T. Waise, M. Kamruzzaman, A. Ghosh, G. Nair et al., The Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System Mediates Resistance of Vibrio cholerae O1 Strains to Multiple Environmental Bacteriophages, Applied and Environmental Microbiology, vol.76, issue.13, pp.4233-4273, 2010.
DOI : 10.1128/AEM.00008-10

M. Waldor, H. Tschäpe, and J. Mekalanos, A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139., Journal of Bacteriology, vol.178, issue.14, pp.4157-658763944, 1996.
DOI : 10.1128/jb.178.14.4157-4165.1996

A. Nielsen, N. Dolganov, T. Rasmussen, G. Otto, M. Miller et al., A Bistable Switch and Anatomical Site Control Vibrio cholerae Virulence Gene Expression in the Intestine, PLoS Pathogens, vol.185, issue.9, 2010.
DOI : 10.1371/journal.ppat.1001102.s013

G. Wegrzyn and M. Thomas, Modulation of the susceptibility of intestinal bacteria to bacteriophages in response to Ag43 phase variation --a hypothesis, Med Sci Monit, vol.8, pp.15-812070443, 2002.

A. Letarov and E. Kulikov, The bacteriophages in human- and animal body-associated microbial communities, Journal of Applied Microbiology, vol.4, issue.1, pp.1-13, 2009.
DOI : 10.1016/S1383-5718(00)00003-6

E. Saussereau and L. Debarbieux, Bacteriophages in the Experimental Treatment of Pseudomonas aeruginosa Infections in Mice, Adv Virus Res, vol.83, pp.123-164, 2012.
DOI : 10.1016/B978-0-12-394438-2.00004-9

D. Maura, M. Galtier, L. Bouguénec, C. Debarbieux, and L. , Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6235-4200602, 2012.
DOI : 10.1128/AAC.00602-12
URL : https://hal.archives-ouvertes.fr/pasteur-01538999

D. Maura, E. Morello, L. Du-merle, P. Bomme, L. Bouguénec et al., Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice, Environmental Microbiology, vol.189, issue.8, pp.1844-54, 2012.
DOI : 10.1128/JB.00838-07

M. Weiss, E. Denou, A. Bruttin, R. Serra-moreno, M. Dillmann et al., In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli, Virology, vol.393, issue.1, pp.16-23, 2009.
DOI : 10.1016/j.virol.2009.07.020

M. Muniesa, J. Hammerl, S. Hertwig, B. Appel, and H. Brüssow, Shiga Toxin-Producing Escherichia coli O104:H4: a New Challenge for Microbiology, Applied and Environmental Microbiology, vol.78, issue.12, pp.4065-7300217, 2012.
DOI : 10.1128/AEM.00217-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370534

L. Kasman, Barriers to coliphage infection of commensal intestinal flora of laboratory mice

A. Reyes, N. Semenkovich, K. Whiteson, F. Rohwer, and J. Gordon, Going viral: next-generation sequencing applied to phage populations in the human gut, Nature Reviews Microbiology, vol.106, issue.9, pp.607-624, 2012.
DOI : 10.1073/pnas.0800442106

A. Reyes, M. Haynes, N. Hanson, F. Angly, A. Heath et al., Viruses in the faecal microbiota of monozygotic twins and their mothers, Nature, vol.11, issue.7304, pp.334-342, 2010.
DOI : 10.1038/nature09199

F. Doucet-populaire, P. Trieu-cuot, I. Dosbaa, A. Andremont, and P. Courvalin, Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice., Antimicrobial Agents and Chemotherapy, vol.35, issue.1, pp.185-192, 1991.
DOI : 10.1128/AAC.35.1.185

A. Andremont, G. Gerbaud, C. Tancrède, and P. Courvalin, Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli, Infect Immun, vol.49, pp.751-53897062, 1985.

B. Duerkop, C. Clements, D. Rollins, J. Rodrigues, and L. Hooper, A composite bacteriophage alters colonization by an intestinal commensal bacterium, Proceedings of the National Academy of Sciences, vol.313, issue.5790, 2012.
DOI : 10.1126/science.1127119
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491505

S. Abedon, S. Kuhl, B. Blasdel, and E. Kutter, Phage treatment of human infections, Bacteriophage, vol.7, issue.2, pp.66-85, 2011.
DOI : 10.1016/S0041-1345(03)00525-6

B. Burrowes, D. Harper, J. Anderson, M. Mcconville, and M. Enright, Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens, Expert Review of Anti-infective Therapy, vol.9, issue.9, pp.775-85, 2011.
DOI : 10.1586/eri.11.90

H. Brüssow, Phage therapy: the Escherichia coli experience, Microbiology, vol.151, issue.7, pp.2133-2173, 2005.
DOI : 10.1099/mic.0.27849-0

M. Clokie, A. Millard, A. Letarov, and S. Heaphy, Phages in nature, Bacteriophage, vol.152, issue.1, pp.31-45, 2011.
DOI : 10.1098/rstb.2009.0036
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109452

S. Ripp and R. Miller, Dynamics of the pseudolysogenic response in slowly growing cells of Pseudomonas aeruginosa, Microbiology, vol.144, issue.8, pp.2225-3200221287, 1998.
DOI : 10.1099/00221287-144-8-2225

R. Miller and M. Day, Contribution of lysogeny, pseudolysogeny, and starvation to phage ecology, pp.114-158, 2008.
DOI : 10.1017/CBO9780511541483.008

M. Los, G. Wegrzyn, and P. Neubauer, A role for bacteriophage T4 rI gene function in the control of phage development during pseudolysogeny and in slowly growing host cells, Research in Microbiology, vol.154, issue.8, pp.547-52, 2003.
DOI : 10.1016/S0923-2508(03)00151-7

S. Abedon, Facilitation of CRISPR adaptation, Bacteriophage, vol.1, issue.3, pp.179-81, 2011.
DOI : 10.1098/rspb.2010.0055

H. Brüssow, What is needed for phage therapy to become a reality in Western medicine?, Virology, vol.434, issue.2, pp.138-180, 2012.
DOI : 10.1016/j.virol.2012.09.015